R Andrews
Fri 09 14:00
S17
Symposium 6
Physiology of exercise and endurance sport in type 1 diabetes
Steve Ball
Manchester, United Kingdom
Wed 07
Ferring Pharmaceuticals Satellite Symposium
Other forms of salt and water disturbance
Manchester, United Kingdom
J Bellringer
Thu 08 11:30
S8
Symposium 1
Gender reassignment surgery in GID
P Carmichael
Thu 08 11:00
S7
Symposium 1
The development of sexual identity and understanding of GID
C Chu
Thu 08 14:00
S10
Symposium 2
MEN Syndromes- the genetics and ethics of screening
S Heller
Fri 09 09:00
S13
Symposium 4
Improving outcomes in teenagers and young adults with Type 1 diabetes
R Holt
Thu 08 16:00
S11
Symposium 3
Beyond reasonable doubt – catching the GH cheats
K Lange
Hannover, Germany
Fri 09 09:30
S14
Symposium 4
Continuous age appropriate structured education for children and young people with diabetes
Hannover, Germany
N Lovell
Fri 09
S15
Symposium 5
Structured Knowledge and Information Programme-the SKIP course
Mohamad Maghnie
Genova, Italy
Wed 07
Ferring Pharmaceuticals Satellite Symposium
Diabetes Insipidus and Pituitary Stalk Abnormalities
Genova, Italy
M Maghnie
Genova, Italy
Thu 08 13:30
S9
Symposium 2
Growth Hormone in transition
Genova, Italy
M Marshall
Fri 09
S16
Symposium 5
How paediatric diabetes nurse specialists support schools
J Pickup
Fri 09 15:00
S19
Keynote Lecture
Insulin pumps and continuous monitoring: evidence for their role in the management of diabetes
G Regan
Fri 09 14:30
S18
Symposium 6
Optimising sports performance and nutrition in type 1 diabetes
A Rogol
Virginia, USA
Thu 08 16:30
S12
Symposium 3
Physical Activity and Athletic Training in Children and Adolescents
Virginia, USA
Wed 07 16:00
Registration
Leeds Town Hall
Wed 07 16:45
Registration
Leeds City Museum, Leeds
Wed 07
Ferring Pharmaceuticals Satellite Symposium
Diabetes Insipidus and Pituitary Stalk Abnormalities
Genova, Italy
Wed 07
Ferring Pharmaceuticals Satellite Symposium
Other forms of salt and water disturbance
Manchester, United Kingdom
Wed 07 19:00
Welcome Reception
Leeds City Museum, Leeds
Thu 08 08:45
Welcome
Chairs: S Alvi (Leeds) & T Mushtaq (Leeds)
Thu 08
OC1.1
Oral Communications 1
Iodine status in UK pregnant women and implications for fetal brain development
Thu 08
OC1.2
Oral Communications 1
Disease- and treatment-related factors implicated in late neuroendocrine morbidity after paediatric optic pathway gliomas: a preliminary multivariate analysis of 96 patients treated over 30 years.
Thu 08
OC1.3
Oral Communications 1
Potential novel insights into the control of the feto-placental unit by kisspeptin.
Thu 08
OC1.4
Oral Communications 1
Skeletal effects of hypothyroidism are mediated by thyroid hormone receptor alpha.
Thu 08
OC1.5
Oral Communications 1
Ethnic Differences In Vascular Growth Factor Levels In Early Life In Relation To Arterial Stiffness In The Manchester Heart And Growth Study
Thu 08
OC1.6
Oral Communications 1
A novel syndrome characterized by hypothalamic hormonal insufficiency, neonatal seizures, congenital abnormalities of the kidneys and urinary tract and obesity due to mutation in a gene regulating hypothalamic development
Thu 08
OC1.7
Oral Communications 1
Novel therapies herald novel diseases: The first paediatric case series of Graves’ immune reconstitution disease
Thu 08
OC1.8
Oral Communications 1
Loss-of-Function Mutations in IGSF1 Cause a Novel, X-Linked Syndrome of Central Hypothyroidism and Testicular Enlargement
Thu 08 10:30
Tea & Coffee
Thu 08 11:00
S7
Symposium 1
The development of sexual identity and understanding of GID
Thu 08 11:30
S8
Symposium 1
Gender reassignment surgery in GID
Thu 08 12:00
Lunch
Thu 08 12:45
Poster Tour
Thu 08 13:30
S9
Symposium 2
Growth Hormone in transition
Genova, Italy
Thu 08 14:00
S10
Symposium 2
MEN Syndromes- the genetics and ethics of screening
Thu 08
OC2.1
Oral Communications 2
Assessment of adrenal function in Female to Male adolescents with Gender Identity Dysphoria (GID).
Thu 08
OC2.2
Oral Communications 2
Deficiency of the triple A syndrome gene product, ALADIN, renders human adrenal cells susceptible to oxidative stress with subsequent impact on steroidogenesis
Thu 08
OC2.3
Oral Communications 2
Does Vitamin D modulate mitochondrial oxidative phosphorylation?
Thu 08
OC2.4
Oral Communications 2
Prenatal Dexamethasone For Treatment Of Congenital Adrenal Hyperplasia: A Possible Association With Late Gestational Fetal Demise In Two Cases.
Thu 08
OC2.5
Oral Communications 2
Abnormal neurological and developmental outcomes in children with persistent and spontaneously resolving congenital hyperinsulinism
Thu 08
OC2.6
Oral Communications 2
Childhood body composition is associated with maternal plasma polyunsaturated fatty acids status in late pregnancy
Thu 08
OC2.7
Oral Communications 2
Growth, GH-IGF-I Status and Response to r-hGH Therapy in 3-M Syndrome, Related to Mutation Status
Thu 08
OC2.8
Oral Communications 2
Genetic screening in a large cohort of patients with congenital hypopituitarism; current knowledge and future directions.
Thu 08
OC2.9
Oral Communications 2
Growth hormone (GH) neuro-secretory dysfunction following traumatic brain injury (TBI) in childhood
Thu 08
OC2.10
Oral Communications 2
When is it justifiable to await venous thyroid function tests before starting thyroxine treatment in infants referred with capillary TSH elevation?
Thu 08 15:30
Tea & Coffee
Thu 08 16:00
S11
Symposium 3
Beyond reasonable doubt – catching the GH cheats
Thu 08 16:30
S12
Symposium 3
Physical Activity and Athletic Training in Children and Adolescents
Virginia, USA
Thu 08 17:15
BSPED Annual General Meeting
Thu 08 19:15
Pre-Dinner Welcome Reception
Thu 08 20:00
Conference Dinner
Fri 09 08:15
Registrations Opens
Fri 09 09:00
S13
Symposium 4
Improving outcomes in teenagers and young adults with Type 1 diabetes
Fri 09 09:30
S14
Symposium 4
Continuous age appropriate structured education for children and young people with diabetes
Hannover, Germany
Fri 09
OC3.1
Oral Communications 3
HbA1c league tables: Does selection policy encourage foul play to support promotion to the “premier league”?
Fri 09
OC3.2
Oral Communications 3
Audit of management of diabetic ketoacidosis in children
Fri 09
OC3.3
Oral Communications 3
Quality of Life and HbA1c outcomes in children and young people commencing insulin pump therapy
Fri 09
OC3.4
Oral Communications 3
Continuous Glucose Monitoring - Are there more barriers than benefits?
Fri 09
OC3.5
Oral Communications 3
Childhood Type I Diabetes Education at Time of Diagnosis- what Patients Want to Know
Fri 09 10:30
Tea & Coffee
Fri 09
OC4.1
Oral Communications 4
Metformin in Obese Children and Adolescents: the MOCA trial
Fri 09
OC4.2
Oral Communications 4
Patterns of presentation and initial management of type I diabetes mellitus in the UK: the Early Care Survey
Fri 09
OC4.3
Oral Communications 4
White UK children are older, more obese and more insulin resistant than non-White UK children at diagnosis of type 2 diabetes: baseline results of the UK national Type 2 diabetes cohort
Fri 09
OC4.4
Oral Communications 4
Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 (WFS1) protein, which regulates its stability and expression.
Fri 09
OC4.5
Oral Communications 4
The effect of insulin intensification on glycaemic control and lipid levels in children and young persons with type 1 diabetes differs in relation to ethnic group
Fri 09
S15
Symposium 5
Structured Knowledge and Information Programme-the SKIP course
Fri 09
S16
Symposium 5
How paediatric diabetes nurse specialists support schools
Fri 09 12:45
BSPED Prizes
Fri 09 13:00
Lunch
Fri 09 14:00
S17
Symposium 6
Physiology of exercise and endurance sport in type 1 diabetes
Fri 09 14:30
S18
Symposium 6
Optimising sports performance and nutrition in type 1 diabetes
Fri 09 15:00
S19
Keynote Lecture
Insulin pumps and continuous monitoring: evidence for their role in the management of diabetes
Fri 09 15:45
Closing remarks

0 result(s) found.